Best Blood Investigation for a 43-Year-Old Woman
For a 43-year-old woman, diabetes screening with HbA1c, fasting plasma glucose (FPG), or 2-hour oral glucose tolerance test (OGTT) is the most appropriate blood investigation, as this age group falls within the recommended universal screening threshold of 35 years and older. 1
Primary Recommendation: Diabetes Screening
The 2023 guidelines explicitly recommend that all asymptomatic adults aged 35 years or older should be screened for diabetes in a healthcare setting 1. At 43 years old, this patient meets the age criterion regardless of other risk factors.
Acceptable Testing Options (Choose One):
- HbA1c ≥6.5% (48 mmol/mol) indicates diabetes
- Fasting plasma glucose ≥7.0 mmol/L (126 mg/dL) indicates diabetes
- 2-hour plasma glucose during OGTT ≥11.1 mmol/L (200 mg/dL) indicates diabetes 1
Interpretation Thresholds:
Normal results:
- FPG <5.6 mmol/L (<100 mg/dL)
- 2-h plasma glucose <7.8 mmol/L (<140 mg/dL)
- HbA1c <5.7% (<39 mmol/mol)
If normal, repeat screening at 3-year intervals 1.
Prediabetes range (requires annual testing):
- FPG 5.6-6.9 mmol/L (100-125 mg/dL)
- 2-h plasma glucose 7.8-11.0 mmol/L (140-199 mg/dL)
- HbA1c 5.7-6.4% (39-47 mmol/mol) 2
Additional Considerations Based on Risk Factors
Screen more frequently or add additional tests if the patient has:
- BMI ≥25 kg/m² (≥23 kg/m² if Asian American) PLUS any of:
- First-degree relative with diabetes
- History of cardiovascular disease
- Hypertension (≥140/90 mmHg or on therapy)
- HDL cholesterol <35 mg/dL or triglycerides >250 mg/dL
- Polycystic ovary syndrome
- Physical inactivity
- History of gestational diabetes 2
Important Caveats
Diagnostic requirements: In the absence of clear hyperglycemia symptoms, diagnosis requires two abnormal results—either from different tests on the same day or repeated testing on different days 1.
Laboratory standards: HbA1c must be performed in a laboratory using NGSP-certified methods standardized to the DCCT assay. Point-of-care assays should NOT be used for diagnosis 1.
Undiagnosed disease burden: Approximately 25% of people with type 2 diabetes in the U.S. are undiagnosed, with complications potentially beginning years before clinical diagnosis 1. This underscores the critical importance of screening at this age.
Why Not Other Tests?
The evidence provided focuses heavily on diabetes screening as the priority blood investigation for this age group. While the research evidence discusses bleeding disorders 3, 4, 5, 6, 7, these investigations are only warranted when there is a personal/family history of bleeding or suggestive symptoms—not as routine screening in an asymptomatic 43-year-old woman.
The guideline evidence clearly prioritizes diabetes screening as the standard of care for this age group, making it the most appropriate "best" blood investigation without additional clinical context. 1, 2